Litcius/Paper detail

Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond

Mengting Li, Muhsin H. Younis, Yongxue Zhang, Weibo Cai, Xiaoli Lan

2022European Journal of Nuclear Medicine and Molecular Imaging124 citationsDOIOpen Access PDF

Topics & Concepts

Fibroblast activation protein, alphaMedicineCancer researchCancerClinical trialRadiation therapyFibroblastDOTAPathologyIn vitroInternal medicineChemistryIn vivoBiologyBiochemistryBiotechnologyPeptidase Inhibition and AnalysisCardiac Structural Anomalies and RepairProtease and Inhibitor Mechanisms
Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond | Litcius